Skip to main content

Advertisement

SpringerLink
Log in

Carfilzomib: a rare cause of posterior reversible encephalopathy syndrome

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kelly K, Kalachand R, Murphy P (2008) Bortezomib-induced reversible posterior leucoencephalopathy syndrome. Br J Haematol 141:566

    Article  PubMed  Google Scholar 

  2. Kager LM, Kersten MJ, Kloppenborg RP, Van Oers R, & Van den Born BJ (2009) Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma. BMJ Case Reports. doi:http://doi.org/10.1136/bcr.06.2009.1926

  3. Terwiel E, Hanrahan R, Lueck C et al (2010) Reversible posterior encephalopathy syndrome associated with bortezomib. Intern Med J 40:69–71

    Article  CAS  PubMed  Google Scholar 

  4. Oshikawa G, Kojima A, Doki N, Kobayashi T, Kakihana K, Tsuda H, Endo I, Kamata N, Ohashi K, Sakamaki H (2013) Bortezomib-induced posterior reversible encephalopathy syndrome in a patient with newly diagnosed multiple myeloma. Intern Med 52(1):111–114

    Article  PubMed  Google Scholar 

  5. Cai X, Bhattacharyya S, Plitt A, Raibagkar P, LaBuzetta JN, Schleicher SM, Munshi NC, Klein JP (2016) Management of posterior reversible encephalopathy syndrome induced by carfilzomib in a patient with multiple myeloma. J Clin Oncol 34(2):e1–e5

    Article  PubMed  Google Scholar 

  6. Pauff JM, Ayres KL, Sochacki AL, Morgan D, Strother MK, Goemann M, Warner JL (2015) Reversible posterior leukoencephalopathy syndrome due to carfilzomib. Ann Hematol Oncol 2(1):1018

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, The University of Texas Houston, Health Science Center, Houston, TX, USA

    Nurit Katz-Agranov & Joanna Scoon

  2. Department of Neurology, The University of Texas, Health Science Center, Houston, TX, USA

    Jennifer Padilla

  3. Department of Pulmonary Critical Care and Sleep Medicine, The University of Texas, Health Science Center, Houston, TX, USA

    Sujith V. Cherian

Authors
  1. Nurit Katz-Agranov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Padilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanna Scoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sujith V. Cherian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nurit Katz-Agranov.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katz-Agranov, N., Padilla, J., Scoon, J. et al. Carfilzomib: a rare cause of posterior reversible encephalopathy syndrome. Ann Hematol 95, 1923–1924 (2016). https://doi.org/10.1007/s00277-016-2769-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2769-9

Keywords

Search

Navigation